Sarissa Capital Management LP Amarin Corp Plcuk Transaction History
Sarissa Capital Management LP
- $592 Million
- Q2 2024
A detailed history of Sarissa Capital Management LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Sarissa Capital Management LP holds 24,850,623 shares of AMRN stock, worth $14.9 Million. This represents 2.89% of its overall portfolio holdings.
Number of Shares
24,850,623
Previous 24,850,623
-0.0%
Holding current value
$14.9 Million
Previous $22.1 Million
22.48%
% of portfolio
2.89%
Previous 3.87%
Shares
8 transactions
Others Institutions Holding AMRN
# of Institutions
188Shares Held
76.5MCall Options Held
247KPut Options Held
121K-
Kynam Capital Management, LP Princeton, NJ12.2MShares$7.29 Million0.65% of portfolio
-
Dg Capital Management, LLC New York, NY5.12MShares$3.07 Million1.36% of portfolio
-
Eversept Partners, LP New York, NY4.31MShares$2.59 Million0.22% of portfolio
-
Two Sigma Investments, LP New York, NY3.04MShares$1.82 Million0.01% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny2.59MShares$1.55 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $242M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...